Is DiaSys Corp halal to invest in?

According to Musaffa's Shariah screening methodology, DiaSys Corp (DYXC) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is DiaSys Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes DiaSys Corp using these criteria to determine its compliance status.

Can Muslims buy shares of DiaSys Corp?

Muslim investors may consider investing in DiaSys Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is DiaSys Corp classified as NOT COVERED?

Musaffa determines the Shariah status of DiaSys Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for DiaSys Corp updated?

The Shariah compliance status of DiaSys Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like DiaSys Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of DiaSys Corp?

You can check the latest Shariah compliance status of DiaSys Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

DiaSys Corp. Stock Analysis DYXC

United States Health Care Nano Cap

DiaSys Corp. operates as a health card company engaged in the design, development, manufacture and distribution of workstation instruments, consumables, reagents and specialized test kits to hospital, clinical and private physician laboratories. The company is headquartered in Waterbury, Connecticut and currently employs 10 full-time employees. The Company’s workstation instruments standardize laboratory analysis of urine sediment, fecal concentrates, cerebral spinal fluid (CSF), fine needle aspirations (FNA) and other cell suspensions. The Company’s wholly owned subsidiary, DiaSys Europe Limited markets the Company’s urinalysis and parasitology workstations, the full DiaSys line of rapid test kits, consumables, immunology, oncology and virology products and manufactures reagents. The two product categories of the Company are workstation-systems, and disposable consumables, diagnostic test products and kits. DiaSys sells its products in North America both directly and through strategic distribution relationships with Cardinal Heath and Fisher Healthcare.

Financial Metrics & Statements of DiaSys Corp (DYXC)

FAQ's for DiaSys Corp (DYXC)

According to Musaffa’s Shariah screening methodology, DiaSys Corp (DYXC) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.